Femilon is a combined oral contraceptive medication that contains synthetic estrogen and progestin components. It is prescribed to prevent unintended pregnancy and to regulate irregular menstrual cycles. The synthetic estrogen component suppresses the hypothalamic-pituitary axis to reduce gonadotropin secretion. This inhibition prevents follicular maturation and thereby blocks the release of a mature oocyte. The progestin component thickens cervical mucus to impede sperm penetration and alters the uterine lining to reduce implantation potential. Through these actions the drug modulates hormone-driven processes that control ovulation, cervical secretions, and endometrial receptivity. Together the hormones produce a reliable contraceptive effect by combining suppression of ovulation with barriers to fertilization.

Femilon is a combined oral contraceptive that contains the synthetic estrogen ethinylestradiol and the synthetic progestin levonorgestrel. The medication is supplied as an oral tablet taken once daily for continuous contraceptive effect. Its pharmacological action works by suppressing the release of follicle-stimulating hormone and luteinizing hormone through negative feedback on the hypothalamic-pituitary axis. This hormonal suppression prevents the development of a mature ovarian follicle and thus ovulation. In addition the progestin component thickens cervical mucus making it hostile to sperm migration. The combined effect alters the endometrial lining reducing its receptivity to implantation. These mechanisms together provide reliable birth control when the tablet is used as prescribed. The drug is classified as a combined hormonal contraceptive and is used solely for preventing pregnancy.

Femilon may cause occasional nausea or stomach discomfort. Some users report mild headaches that usually resolve without intervention. Swelling of the ankles or feet can occur due to fluid retention. Breast tenderness is reported in a minority of patients. Skin changes such as rash or itching may appear temporarily. Weight fluctuations are sometimes observed but are not consistent. Mild dizziness may be experienced, especially when standing quickly. Most side effects are transient and subside as the body adjusts.

Femilon may cause nausea in some users. Headache is also reported. Breast tenderness can occur. Spotting or irregular bleeding may happen. Weight changes are occasionally noted. Mood alterations have been observed.